Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
選択的エストロゲン受容体分解剤
Document Type and Number:
Japanese Patent JP2021530486
Kind Code:
A
Abstract:
式:【化1】による新規の選択的エストロゲン受容体分解物(SERD)、その薬学的に許容される塩、薬学的組成物、使用、およびそれらの使用方法が提供される。

Inventors:
Cohen, Jeffrey Daniel
Monkey, Daniel John
Application Number:
JP2021500586A
Publication Date:
November 11, 2021
Filing Date:
July 11, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Eli Lilly and Company
International Classes:
C07D401/12; A61K31/4709; A61K31/4741; A61K45/00; A61P35/00; A61P43/00; C07D491/052
Domestic Patent References:
JP2018504384A2018-02-15
JP2006504629A2006-02-09
JP2007519721A2007-07-19
JP2004531562A2004-10-14
JP2006514941A2006-05-18
Foreign References:
US20080221163A12008-09-11
Other References:
HUSSAIN, M. K ET AL., RSC ADVANCES, vol. 4, JPN6022001267, 2014, pages 8828 - 8845, ISSN: 0004685303
WALLACE, O. B ET AL., JOURNAL OF MEDICINAL CHEMISTRY, vol. 49, no. 3, JPN6022001266, 2006, pages 843 - 846, ISSN: 0004685304
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Inori Toshihiro
Yasuhito Suzuki



 
Previous Patent: How to treat cancer

Next Patent: EP4 inhibitor and its synthesis